Georgios Giamas: Different CRISPR Screening Approaches Used in Breast Cancer Research
Georgios Giamas, Editor in Chief of Cancer Gene Therapy (CGT), shared a post on LinkedIn:
“New review paper from our lab discussing different CRISPR screening approaches used in breast cancer research.”
The G.LA.R.E. Laboratory (Giamas Translational Cancer Research Lab; GLARE.BIO) focuses on advancing precision oncology by identifying and targeting key proteins and genes involved in cancer progression. Through a combination of molecular, cellular, and biochemical methods with clinically validated models, the lab connects fundamental research with real-world clinical applications.
Their work aims to translate discoveries into new therapies and diagnostic tools, helping to drive personalised cancer care forward and address critical needs in oncology treatment and management.
Read more by following this link.
More posts featuring Georgios Giamas.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023